nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2D6—Fingolimod—multiple sclerosis	0.0783	0.223	CbGbCtD
Irbesartan—CYP3A4—Fingolimod—multiple sclerosis	0.0498	0.142	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—multiple sclerosis	0.0321	0.0915	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—multiple sclerosis	0.0299	0.0853	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—multiple sclerosis	0.0243	0.0693	CbGbCtD
Irbesartan—CYP3A4—Mitoxantrone—multiple sclerosis	0.0234	0.0667	CbGbCtD
Irbesartan—CYP2C9—Dexamethasone—multiple sclerosis	0.0209	0.0595	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—multiple sclerosis	0.0209	0.0595	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—multiple sclerosis	0.0206	0.0587	CbGbCtD
Irbesartan—CYP3A4—Prednisone—multiple sclerosis	0.0194	0.0554	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—multiple sclerosis	0.0191	0.0544	CbGbCtD
Irbesartan—CYP3A4—Dexamethasone—multiple sclerosis	0.0121	0.0346	CbGbCtD
Irbesartan—JUN—peripheral nervous system—multiple sclerosis	0.00757	0.18	CbGeAlD
Irbesartan—JUN—nerve—multiple sclerosis	0.0059	0.14	CbGeAlD
Irbesartan—JUN—brainstem—multiple sclerosis	0.00253	0.0603	CbGeAlD
Irbesartan—JUN—retina—multiple sclerosis	0.00244	0.0582	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—multiple sclerosis	0.00194	0.0461	CbGeAlD
Irbesartan—EDNRA—midbrain—multiple sclerosis	0.00177	0.0421	CbGeAlD
Irbesartan—JUN—medulla oblongata—multiple sclerosis	0.00177	0.042	CbGeAlD
Irbesartan—JUN—midbrain—multiple sclerosis	0.00161	0.0384	CbGeAlD
Irbesartan—JUN—spinal cord—multiple sclerosis	0.00157	0.0375	CbGeAlD
Irbesartan—AGTR1—medulla oblongata—multiple sclerosis	0.00133	0.0317	CbGeAlD
Irbesartan—JUN—nervous system—multiple sclerosis	0.00133	0.0316	CbGeAlD
Irbesartan—JUN—central nervous system—multiple sclerosis	0.00128	0.0304	CbGeAlD
Irbesartan—JUN—cerebellum—multiple sclerosis	0.00125	0.0297	CbGeAlD
Irbesartan—EDNRA—brain—multiple sclerosis	0.00111	0.0265	CbGeAlD
Irbesartan—JUN—brain—multiple sclerosis	0.00101	0.0241	CbGeAlD
Irbesartan—AGTR1—nervous system—multiple sclerosis	0.000999	0.0238	CbGeAlD
Irbesartan—AGTR1—central nervous system—multiple sclerosis	0.000962	0.0229	CbGeAlD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000832	0.105	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Methylprednisolone—multiple sclerosis	0.000832	0.105	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Dexamethasone—multiple sclerosis	0.000819	0.104	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—multiple sclerosis	0.000819	0.104	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Triamcinolone—multiple sclerosis	0.0008	0.101	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—multiple sclerosis	0.0008	0.101	CbGdCrCtD
Irbesartan—AGTR1—brain—multiple sclerosis	0.000764	0.0182	CbGeAlD
Irbesartan—JUN—Dexamethasone—Prednisone—multiple sclerosis	0.000759	0.0961	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisone—multiple sclerosis	0.000759	0.0961	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisolone—multiple sclerosis	0.000741	0.0938	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisolone—multiple sclerosis	0.000741	0.0938	CbGdCrCtD
Irbesartan—CYP2D6—brainstem—multiple sclerosis	0.000689	0.0164	CbGeAlD
Irbesartan—PTGS1—spinal cord—multiple sclerosis	0.000521	0.0124	CbGeAlD
Irbesartan—PTGS1—nervous system—multiple sclerosis	0.000439	0.0105	CbGeAlD
Irbesartan—PTGS1—central nervous system—multiple sclerosis	0.000423	0.0101	CbGeAlD
Irbesartan—CYP2C8—brain—multiple sclerosis	0.000414	0.00986	CbGeAlD
Irbesartan—CYP3A4—nervous system—multiple sclerosis	0.000367	0.00874	CbGeAlD
Irbesartan—CYP2D6—nervous system—multiple sclerosis	0.000361	0.0086	CbGeAlD
Irbesartan—CYP3A4—central nervous system—multiple sclerosis	0.000353	0.00841	CbGeAlD
Irbesartan—CYP2D6—central nervous system—multiple sclerosis	0.000348	0.00828	CbGeAlD
Irbesartan—CYP2D6—cerebellum—multiple sclerosis	0.00034	0.00809	CbGeAlD
Irbesartan—PTGS1—brain—multiple sclerosis	0.000336	0.00799	CbGeAlD
Irbesartan—Valsartan—ALB—multiple sclerosis	0.000335	0.672	CrCbGaD
Irbesartan—CYP2D6—brain—multiple sclerosis	0.000276	0.00657	CbGeAlD
Irbesartan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000229	0.000685	CcSEcCtD
Irbesartan—Syncope—Dexamethasone—multiple sclerosis	0.000229	0.000685	CcSEcCtD
Irbesartan—Syncope—Betamethasone—multiple sclerosis	0.000229	0.000685	CcSEcCtD
Irbesartan—Arrhythmia—Prednisone—multiple sclerosis	0.000228	0.000682	CcSEcCtD
Irbesartan—Infection—Triamcinolone—multiple sclerosis	0.000228	0.000682	CcSEcCtD
Irbesartan—Infection—Methylprednisolone—multiple sclerosis	0.000228	0.000681	CcSEcCtD
Irbesartan—Shock—Triamcinolone—multiple sclerosis	0.000226	0.000676	CcSEcCtD
Irbesartan—Shock—Methylprednisolone—multiple sclerosis	0.000226	0.000674	CcSEcCtD
Irbesartan—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000225	0.000672	CcSEcCtD
Irbesartan—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000225	0.000672	CcSEcCtD
Irbesartan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000224	0.000671	CcSEcCtD
Irbesartan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000224	0.000671	CcSEcCtD
Irbesartan—Epistaxis—Methotrexate—multiple sclerosis	0.000224	0.000671	CcSEcCtD
Irbesartan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000224	0.000671	CcSEcCtD
Irbesartan—Paraesthesia—Prednisolone—multiple sclerosis	0.000224	0.000671	CcSEcCtD
Irbesartan—Tachycardia—Triamcinolone—multiple sclerosis	0.000224	0.00067	CcSEcCtD
Irbesartan—Nausea—Azathioprine—multiple sclerosis	0.000224	0.000669	CcSEcCtD
Irbesartan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000224	0.000669	CcSEcCtD
Irbesartan—Skin disorder—Methylprednisolone—multiple sclerosis	0.000223	0.000666	CcSEcCtD
Irbesartan—Erythema—Prednisone—multiple sclerosis	0.000222	0.000665	CcSEcCtD
Irbesartan—Malnutrition—Prednisone—multiple sclerosis	0.000222	0.000665	CcSEcCtD
Irbesartan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000222	0.000664	CcSEcCtD
Irbesartan—Agranulocytosis—Methotrexate—multiple sclerosis	0.000222	0.000664	CcSEcCtD
Irbesartan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000222	0.000662	CcSEcCtD
Irbesartan—Hypertension—Dexamethasone—multiple sclerosis	0.000221	0.000659	CcSEcCtD
Irbesartan—Hypertension—Betamethasone—multiple sclerosis	0.000221	0.000659	CcSEcCtD
Irbesartan—Asthenia—Mitoxantrone—multiple sclerosis	0.000218	0.000653	CcSEcCtD
Irbesartan—Myalgia—Dexamethasone—multiple sclerosis	0.000217	0.00065	CcSEcCtD
Irbesartan—Myalgia—Betamethasone—multiple sclerosis	0.000217	0.00065	CcSEcCtD
Irbesartan—Anxiety—Dexamethasone—multiple sclerosis	0.000217	0.000648	CcSEcCtD
Irbesartan—Anxiety—Betamethasone—multiple sclerosis	0.000217	0.000648	CcSEcCtD
Irbesartan—Discomfort—Dexamethasone—multiple sclerosis	0.000215	0.000642	CcSEcCtD
Irbesartan—Discomfort—Betamethasone—multiple sclerosis	0.000215	0.000642	CcSEcCtD
Irbesartan—Hypotension—Methylprednisolone—multiple sclerosis	0.000214	0.00064	CcSEcCtD
Irbesartan—Pain—Prednisolone—multiple sclerosis	0.000214	0.000639	CcSEcCtD
Irbesartan—Hepatitis—Methotrexate—multiple sclerosis	0.000214	0.000638	CcSEcCtD
Irbesartan—Pharyngitis—Methotrexate—multiple sclerosis	0.000212	0.000633	CcSEcCtD
Irbesartan—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000211	0.00063	CcSEcCtD
Irbesartan—Vision blurred—Prednisone—multiple sclerosis	0.00021	0.000627	CcSEcCtD
Irbesartan—Urethral disorder—Methotrexate—multiple sclerosis	0.000209	0.000626	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000209	0.000626	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000209	0.000624	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000208	0.000623	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—multiple sclerosis	0.000208	0.000623	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000208	0.000623	CcSEcCtD
Irbesartan—Oedema—Betamethasone—multiple sclerosis	0.000208	0.000623	CcSEcCtD
Irbesartan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000208	0.000623	CcSEcCtD
Irbesartan—Infection—Betamethasone—multiple sclerosis	0.000207	0.000619	CcSEcCtD
Irbesartan—Infection—Dexamethasone—multiple sclerosis	0.000207	0.000619	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisone—multiple sclerosis	0.000206	0.000617	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000206	0.000617	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000206	0.000615	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000206	0.000615	CcSEcCtD
Irbesartan—Visual impairment—Methotrexate—multiple sclerosis	0.000206	0.000615	CcSEcCtD
Irbesartan—Anaemia—Prednisone—multiple sclerosis	0.000206	0.000615	CcSEcCtD
Irbesartan—Shock—Dexamethasone—multiple sclerosis	0.000205	0.000613	CcSEcCtD
Irbesartan—Shock—Betamethasone—multiple sclerosis	0.000205	0.000613	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000205	0.000612	CcSEcCtD
Irbesartan—Nervous system disorder—Betamethasone—multiple sclerosis	0.000204	0.000611	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000204	0.000611	CcSEcCtD
Irbesartan—Agitation—Prednisone—multiple sclerosis	0.000204	0.000611	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000204	0.00061	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000204	0.00061	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—multiple sclerosis	0.000203	0.000608	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—multiple sclerosis	0.000203	0.000608	CcSEcCtD
Irbesartan—Angioedema—Prednisone—multiple sclerosis	0.000203	0.000608	CcSEcCtD
Irbesartan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000202	0.000604	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000202	0.000603	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000202	0.000602	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000202	0.000602	CcSEcCtD
Irbesartan—Malaise—Prednisone—multiple sclerosis	0.000201	0.0006	CcSEcCtD
Irbesartan—Vertigo—Prednisone—multiple sclerosis	0.0002	0.000597	CcSEcCtD
Irbesartan—Syncope—Prednisone—multiple sclerosis	0.000199	0.000596	CcSEcCtD
Irbesartan—Tinnitus—Methotrexate—multiple sclerosis	0.000199	0.000595	CcSEcCtD
Irbesartan—Anorexia—Betamethasone—multiple sclerosis	0.000199	0.000594	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—multiple sclerosis	0.000199	0.000594	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—multiple sclerosis	0.000198	0.000593	CcSEcCtD
Irbesartan—Cardiac disorder—Methotrexate—multiple sclerosis	0.000198	0.000592	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—multiple sclerosis	0.000198	0.000592	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—multiple sclerosis	0.000198	0.000591	CcSEcCtD
Irbesartan—Pain—Triamcinolone—multiple sclerosis	0.000196	0.000587	CcSEcCtD
Irbesartan—Loss of consciousness—Prednisone—multiple sclerosis	0.000195	0.000584	CcSEcCtD
Irbesartan—Hypotension—Betamethasone—multiple sclerosis	0.000195	0.000582	CcSEcCtD
Irbesartan—Hypotension—Dexamethasone—multiple sclerosis	0.000195	0.000582	CcSEcCtD
Irbesartan—Angiopathy—Methotrexate—multiple sclerosis	0.000194	0.000579	CcSEcCtD
Irbesartan—Vomiting—Mitoxantrone—multiple sclerosis	0.000194	0.000579	CcSEcCtD
Irbesartan—Immune system disorder—Methotrexate—multiple sclerosis	0.000193	0.000577	CcSEcCtD
Irbesartan—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000192	0.000575	CcSEcCtD
Irbesartan—Hypertension—Prednisone—multiple sclerosis	0.000192	0.000574	CcSEcCtD
Irbesartan—Rash—Mitoxantrone—multiple sclerosis	0.000192	0.000574	CcSEcCtD
Irbesartan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000192	0.000573	CcSEcCtD
Irbesartan—Chills—Methotrexate—multiple sclerosis	0.000192	0.000573	CcSEcCtD
Irbesartan—Headache—Mitoxantrone—multiple sclerosis	0.000191	0.00057	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00019	0.000568	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00019	0.000568	CcSEcCtD
Irbesartan—Arthralgia—Prednisone—multiple sclerosis	0.000189	0.000566	CcSEcCtD
Irbesartan—Myalgia—Prednisone—multiple sclerosis	0.000189	0.000566	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000189	0.000566	CcSEcCtD
Irbesartan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000189	0.000565	CcSEcCtD
Irbesartan—Anxiety—Prednisone—multiple sclerosis	0.000189	0.000564	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000188	0.000562	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000187	0.00056	CcSEcCtD
Irbesartan—Paraesthesia—Betamethasone—multiple sclerosis	0.000187	0.000559	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000187	0.000559	CcSEcCtD
Irbesartan—Discomfort—Prednisone—multiple sclerosis	0.000187	0.000559	CcSEcCtD
Irbesartan—Erythema—Methotrexate—multiple sclerosis	0.000186	0.000556	CcSEcCtD
Irbesartan—Malnutrition—Methotrexate—multiple sclerosis	0.000186	0.000556	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000184	0.00055	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000183	0.000548	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—multiple sclerosis	0.000183	0.000548	CcSEcCtD
Irbesartan—Urticaria—Triamcinolone—multiple sclerosis	0.000182	0.000546	CcSEcCtD
Irbesartan—Urticaria—Methylprednisolone—multiple sclerosis	0.000182	0.000544	CcSEcCtD
Irbesartan—Dysgeusia—Methotrexate—multiple sclerosis	0.000182	0.000544	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—multiple sclerosis	0.000182	0.000543	CcSEcCtD
Irbesartan—Oedema—Prednisone—multiple sclerosis	0.000182	0.000543	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisone—multiple sclerosis	0.000182	0.000543	CcSEcCtD
Irbesartan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000181	0.000542	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—multiple sclerosis	0.000181	0.000542	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—multiple sclerosis	0.000181	0.000542	CcSEcCtD
Irbesartan—Nausea—Mitoxantrone—multiple sclerosis	0.000181	0.000541	CcSEcCtD
Irbesartan—Infection—Prednisone—multiple sclerosis	0.00018	0.000539	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00018	0.000538	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00018	0.000538	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—multiple sclerosis	0.00018	0.000537	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—multiple sclerosis	0.00018	0.000537	CcSEcCtD
Irbesartan—Shock—Prednisone—multiple sclerosis	0.000179	0.000534	CcSEcCtD
Irbesartan—Pain—Betamethasone—multiple sclerosis	0.000178	0.000533	CcSEcCtD
Irbesartan—Pain—Dexamethasone—multiple sclerosis	0.000178	0.000533	CcSEcCtD
Irbesartan—Nervous system disorder—Prednisone—multiple sclerosis	0.000178	0.000532	CcSEcCtD
Irbesartan—Tachycardia—Prednisone—multiple sclerosis	0.000177	0.00053	CcSEcCtD
Irbesartan—Skin disorder—Prednisone—multiple sclerosis	0.000176	0.000527	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisone—multiple sclerosis	0.000175	0.000525	CcSEcCtD
Irbesartan—Vision blurred—Methotrexate—multiple sclerosis	0.000175	0.000524	CcSEcCtD
Irbesartan—Anorexia—Prednisone—multiple sclerosis	0.000173	0.000517	CcSEcCtD
Irbesartan—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000172	0.000516	CcSEcCtD
Irbesartan—Anaemia—Methotrexate—multiple sclerosis	0.000172	0.000514	CcSEcCtD
Irbesartan—Feeling abnormal—Betamethasone—multiple sclerosis	0.000172	0.000513	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000172	0.000513	CcSEcCtD
Irbesartan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00017	0.000509	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00017	0.000509	CcSEcCtD
Irbesartan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000169	0.000506	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000169	0.000505	CcSEcCtD
Irbesartan—Malaise—Methotrexate—multiple sclerosis	0.000168	0.000501	CcSEcCtD
Irbesartan—Vertigo—Methotrexate—multiple sclerosis	0.000167	0.000499	CcSEcCtD
Irbesartan—Leukopenia—Methotrexate—multiple sclerosis	0.000166	0.000497	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—multiple sclerosis	0.000166	0.000495	CcSEcCtD
Irbesartan—Urticaria—Dexamethasone—multiple sclerosis	0.000166	0.000495	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000165	0.000494	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—multiple sclerosis	0.000165	0.000494	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—multiple sclerosis	0.000165	0.000493	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—multiple sclerosis	0.000165	0.000493	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—multiple sclerosis	0.000165	0.000493	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000165	0.000493	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000165	0.000493	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—multiple sclerosis	0.000164	0.000492	CcSEcCtD
Irbesartan—Losartan—ALB—multiple sclerosis	0.000164	0.328	CrCbGaD
Irbesartan—Paraesthesia—Prednisone—multiple sclerosis	0.000163	0.000487	CcSEcCtD
Irbesartan—Pruritus—Triamcinolone—multiple sclerosis	0.000163	0.000486	CcSEcCtD
Irbesartan—Cough—Methotrexate—multiple sclerosis	0.000162	0.000485	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—multiple sclerosis	0.000162	0.000485	CcSEcCtD
Irbesartan—Dyspepsia—Prednisone—multiple sclerosis	0.00016	0.000478	CcSEcCtD
Irbesartan—Arthralgia—Methotrexate—multiple sclerosis	0.000158	0.000473	CcSEcCtD
Irbesartan—Chest pain—Methotrexate—multiple sclerosis	0.000158	0.000473	CcSEcCtD
Irbesartan—Myalgia—Methotrexate—multiple sclerosis	0.000158	0.000473	CcSEcCtD
Irbesartan—Decreased appetite—Prednisone—multiple sclerosis	0.000158	0.000472	CcSEcCtD
Irbesartan—Rash—Prednisolone—multiple sclerosis	0.000158	0.000471	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—multiple sclerosis	0.000157	0.00047	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000157	0.00047	CcSEcCtD
Irbesartan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000157	0.000469	CcSEcCtD
Irbesartan—Fatigue—Prednisone—multiple sclerosis	0.000157	0.000468	CcSEcCtD
Irbesartan—Headache—Prednisolone—multiple sclerosis	0.000156	0.000468	CcSEcCtD
Irbesartan—Discomfort—Methotrexate—multiple sclerosis	0.000156	0.000467	CcSEcCtD
Irbesartan—Constipation—Prednisone—multiple sclerosis	0.000155	0.000464	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—multiple sclerosis	0.000152	0.000454	CcSEcCtD
Irbesartan—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000152	0.000453	CcSEcCtD
Irbesartan—Dizziness—Methylprednisolone—multiple sclerosis	0.000152	0.000453	CcSEcCtD
Irbesartan—Infection—Methotrexate—multiple sclerosis	0.000151	0.000451	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisone—multiple sclerosis	0.00015	0.000447	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—multiple sclerosis	0.00015	0.000447	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—multiple sclerosis	0.00015	0.000447	CcSEcCtD
Irbesartan—Nervous system disorder—Methotrexate—multiple sclerosis	0.000149	0.000445	CcSEcCtD
Irbesartan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000149	0.000444	CcSEcCtD
Irbesartan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000148	0.000444	CcSEcCtD
Irbesartan—Nausea—Prednisolone—multiple sclerosis	0.000148	0.000444	CcSEcCtD
Irbesartan—Pruritus—Dexamethasone—multiple sclerosis	0.000147	0.000441	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—multiple sclerosis	0.000147	0.000441	CcSEcCtD
Irbesartan—Skin disorder—Methotrexate—multiple sclerosis	0.000147	0.00044	CcSEcCtD
Irbesartan—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000147	0.000438	CcSEcCtD
Irbesartan—Vomiting—Triamcinolone—multiple sclerosis	0.000146	0.000437	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—multiple sclerosis	0.000146	0.000436	CcSEcCtD
Irbesartan—Rash—Triamcinolone—multiple sclerosis	0.000145	0.000433	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—multiple sclerosis	0.000145	0.000433	CcSEcCtD
Irbesartan—Anorexia—Methotrexate—multiple sclerosis	0.000145	0.000432	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—multiple sclerosis	0.000145	0.000432	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000144	0.000432	CcSEcCtD
Irbesartan—Urticaria—Prednisone—multiple sclerosis	0.000144	0.000431	CcSEcCtD
Irbesartan—Headache—Triamcinolone—multiple sclerosis	0.000144	0.00043	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—multiple sclerosis	0.000144	0.000429	CcSEcCtD
Irbesartan—Abdominal pain—Prednisone—multiple sclerosis	0.000143	0.000429	CcSEcCtD
Irbesartan—Body temperature increased—Prednisone—multiple sclerosis	0.000143	0.000429	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—multiple sclerosis	0.000143	0.000426	CcSEcCtD
Irbesartan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000143	0.000426	CcSEcCtD
Irbesartan—Hypotension—Methotrexate—multiple sclerosis	0.000142	0.000424	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000138	0.000413	CcSEcCtD
Irbesartan—Dizziness—Betamethasone—multiple sclerosis	0.000138	0.000412	CcSEcCtD
Irbesartan—Dizziness—Dexamethasone—multiple sclerosis	0.000138	0.000412	CcSEcCtD
Irbesartan—Nausea—Triamcinolone—multiple sclerosis	0.000136	0.000408	CcSEcCtD
Irbesartan—Paraesthesia—Methotrexate—multiple sclerosis	0.000136	0.000407	CcSEcCtD
Irbesartan—Nausea—Methylprednisolone—multiple sclerosis	0.000136	0.000407	CcSEcCtD
Irbesartan—Dyspnoea—Methotrexate—multiple sclerosis	0.000135	0.000404	CcSEcCtD
Irbesartan—Somnolence—Methotrexate—multiple sclerosis	0.000135	0.000403	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisone—multiple sclerosis	0.000134	0.0004	CcSEcCtD
Irbesartan—Dyspepsia—Methotrexate—multiple sclerosis	0.000134	0.000399	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—multiple sclerosis	0.000133	0.000396	CcSEcCtD
Irbesartan—Vomiting—Betamethasone—multiple sclerosis	0.000133	0.000396	CcSEcCtD
Irbesartan—Decreased appetite—Methotrexate—multiple sclerosis	0.000132	0.000394	CcSEcCtD
Irbesartan—Rash—Betamethasone—multiple sclerosis	0.000131	0.000393	CcSEcCtD
Irbesartan—Rash—Dexamethasone—multiple sclerosis	0.000131	0.000393	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—multiple sclerosis	0.000131	0.000392	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—multiple sclerosis	0.000131	0.000392	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000131	0.000392	CcSEcCtD
Irbesartan—Fatigue—Methotrexate—multiple sclerosis	0.000131	0.000391	CcSEcCtD
Irbesartan—Headache—Betamethasone—multiple sclerosis	0.000131	0.00039	CcSEcCtD
Irbesartan—Headache—Dexamethasone—multiple sclerosis	0.000131	0.00039	CcSEcCtD
Irbesartan—Asthenia—Prednisone—multiple sclerosis	0.00013	0.000389	CcSEcCtD
Irbesartan—Pain—Methotrexate—multiple sclerosis	0.00013	0.000388	CcSEcCtD
Irbesartan—Pruritus—Prednisone—multiple sclerosis	0.000128	0.000384	CcSEcCtD
Irbesartan—Feeling abnormal—Methotrexate—multiple sclerosis	0.000125	0.000374	CcSEcCtD
Irbesartan—Diarrhoea—Prednisone—multiple sclerosis	0.000124	0.000371	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000124	0.000371	CcSEcCtD
Irbesartan—Nausea—Betamethasone—multiple sclerosis	0.000124	0.00037	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—multiple sclerosis	0.000124	0.00037	CcSEcCtD
Irbesartan—Urticaria—Methotrexate—multiple sclerosis	0.000121	0.00036	CcSEcCtD
Irbesartan—Dizziness—Prednisone—multiple sclerosis	0.00012	0.000359	CcSEcCtD
Irbesartan—Abdominal pain—Methotrexate—multiple sclerosis	0.00012	0.000358	CcSEcCtD
Irbesartan—Body temperature increased—Methotrexate—multiple sclerosis	0.00012	0.000358	CcSEcCtD
Irbesartan—Vomiting—Prednisone—multiple sclerosis	0.000115	0.000345	CcSEcCtD
Irbesartan—Rash—Prednisone—multiple sclerosis	0.000114	0.000342	CcSEcCtD
Irbesartan—Dermatitis—Prednisone—multiple sclerosis	0.000114	0.000342	CcSEcCtD
Irbesartan—Headache—Prednisone—multiple sclerosis	0.000114	0.00034	CcSEcCtD
Irbesartan—Hypersensitivity—Methotrexate—multiple sclerosis	0.000112	0.000334	CcSEcCtD
Irbesartan—Asthenia—Methotrexate—multiple sclerosis	0.000109	0.000325	CcSEcCtD
Irbesartan—Nausea—Prednisone—multiple sclerosis	0.000108	0.000322	CcSEcCtD
Irbesartan—Pruritus—Methotrexate—multiple sclerosis	0.000107	0.000321	CcSEcCtD
Irbesartan—Diarrhoea—Methotrexate—multiple sclerosis	0.000104	0.00031	CcSEcCtD
Irbesartan—Dizziness—Methotrexate—multiple sclerosis	0.0001	0.0003	CcSEcCtD
Irbesartan—Vomiting—Methotrexate—multiple sclerosis	9.65e-05	0.000288	CcSEcCtD
Irbesartan—Rash—Methotrexate—multiple sclerosis	9.57e-05	0.000286	CcSEcCtD
Irbesartan—Dermatitis—Methotrexate—multiple sclerosis	9.56e-05	0.000286	CcSEcCtD
Irbesartan—Headache—Methotrexate—multiple sclerosis	9.5e-05	0.000284	CcSEcCtD
Irbesartan—Nausea—Methotrexate—multiple sclerosis	9.01e-05	0.000269	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—multiple sclerosis	7.83e-05	0.000296	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD86—multiple sclerosis	7.82e-05	0.000296	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL3—multiple sclerosis	7.64e-05	0.000289	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.64e-05	0.000289	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.64e-05	0.000289	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—multiple sclerosis	7.63e-05	0.000288	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.58e-05	0.000287	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—MAPK1—multiple sclerosis	7.58e-05	0.000287	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-G—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFIH1—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRF8—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP27B1—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP24A1—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.57e-05	0.000286	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR5—multiple sclerosis	7.54e-05	0.000285	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—MAPK1—multiple sclerosis	7.45e-05	0.000282	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2RA—multiple sclerosis	7.43e-05	0.000281	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.43e-05	0.000281	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.42e-05	0.000281	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.41e-05	0.00028	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.4e-05	0.00028	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	7.4e-05	0.00028	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTGER4—multiple sclerosis	7.35e-05	0.000278	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	7.35e-05	0.000278	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HLA-B—multiple sclerosis	7.29e-05	0.000276	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—multiple sclerosis	7.27e-05	0.000275	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.27e-05	0.000275	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RGS1—multiple sclerosis	7.25e-05	0.000274	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PGR—multiple sclerosis	7.24e-05	0.000274	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCL5—multiple sclerosis	7.23e-05	0.000273	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCR3—multiple sclerosis	7.1e-05	0.000269	CbGpPWpGaD
Irbesartan—JUN—Immune System—TNFAIP3—multiple sclerosis	7.09e-05	0.000268	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.06e-05	0.000267	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD28—multiple sclerosis	7.04e-05	0.000266	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SRM—multiple sclerosis	6.94e-05	0.000262	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.94e-05	0.000262	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GPC5—multiple sclerosis	6.92e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.92e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.92e-05	0.000262	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR2—multiple sclerosis	6.91e-05	0.000261	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—GPR65—multiple sclerosis	6.87e-05	0.00026	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	6.74e-05	0.000255	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.7e-05	0.000253	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL5—multiple sclerosis	6.56e-05	0.000248	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR5—multiple sclerosis	6.51e-05	0.000246	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.5e-05	0.000246	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—POMC—multiple sclerosis	6.49e-05	0.000245	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—POMC—multiple sclerosis	6.43e-05	0.000243	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	6.42e-05	0.000243	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD28—multiple sclerosis	6.38e-05	0.000241	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CNR1—multiple sclerosis	6.38e-05	0.000241	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—STAT3—multiple sclerosis	6.3e-05	0.000238	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR1—multiple sclerosis	6.29e-05	0.000238	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL13—multiple sclerosis	6.29e-05	0.000238	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTPRC—multiple sclerosis	6.26e-05	0.000237	CbGpPWpGaD
Irbesartan—JUN—Immune System—CCR2—multiple sclerosis	6.26e-05	0.000237	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—multiple sclerosis	6.18e-05	0.000234	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	6.06e-05	0.000229	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DPB1—multiple sclerosis	6.06e-05	0.000229	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL3—multiple sclerosis	5.99e-05	0.000227	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR5—multiple sclerosis	5.91e-05	0.000224	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—POMC—multiple sclerosis	5.89e-05	0.000223	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—BCHE—multiple sclerosis	5.85e-05	0.000221	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2RA—multiple sclerosis	5.83e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Immune System—ITGA4—multiple sclerosis	5.82e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40—multiple sclerosis	5.82e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—multiple sclerosis	5.82e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNB1—multiple sclerosis	5.78e-05	0.000219	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTGER4—multiple sclerosis	5.77e-05	0.000218	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—multiple sclerosis	5.76e-05	0.000218	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—multiple sclerosis	5.74e-05	0.000217	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—multiple sclerosis	5.74e-05	0.000217	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—RRM1—multiple sclerosis	5.74e-05	0.000217	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—MAPK1—multiple sclerosis	5.73e-05	0.000217	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD80—multiple sclerosis	5.7e-05	0.000216	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SRM—multiple sclerosis	5.7e-05	0.000215	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PGR—multiple sclerosis	5.68e-05	0.000215	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SRM—multiple sclerosis	5.65e-05	0.000214	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCR3—multiple sclerosis	5.57e-05	0.000211	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD28—multiple sclerosis	5.52e-05	0.000209	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—multiple sclerosis	5.47e-05	0.000207	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR2—multiple sclerosis	5.42e-05	0.000205	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.28e-05	0.0002	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.24e-05	0.000198	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TYK2—multiple sclerosis	5.23e-05	0.000198	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—POMC—multiple sclerosis	5.09e-05	0.000192	CbGpPWpGaD
Irbesartan—JUN—Immune System—VCAM1—multiple sclerosis	5.07e-05	0.000192	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQA1—multiple sclerosis	5.05e-05	0.000191	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD86—multiple sclerosis	5.02e-05	0.00019	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CNR1—multiple sclerosis	5e-05	0.000189	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL5—multiple sclerosis	4.94e-05	0.000187	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.89e-05	0.000185	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.89e-05	0.000185	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SRM—multiple sclerosis	4.83e-05	0.000183	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TYK2—multiple sclerosis	4.81e-05	0.000182	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—multiple sclerosis	4.8e-05	0.000181	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.78e-05	0.000181	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQB1—multiple sclerosis	4.73e-05	0.000179	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—POMC—multiple sclerosis	4.62e-05	0.000175	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SPP1—multiple sclerosis	4.58e-05	0.000173	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD86—multiple sclerosis	4.55e-05	0.000172	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—multiple sclerosis	4.52e-05	0.000171	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—multiple sclerosis	4.5e-05	0.00017	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL3—multiple sclerosis	4.48e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.47e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.47e-05	0.000169	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—multiple sclerosis	4.46e-05	0.000169	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—multiple sclerosis	4.45e-05	0.000168	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.45e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—multiple sclerosis	4.41e-05	0.000167	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—multiple sclerosis	4.4e-05	0.000166	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2RA—multiple sclerosis	4.39e-05	0.000166	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—multiple sclerosis	4.35e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—multiple sclerosis	4.35e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTGER4—multiple sclerosis	4.31e-05	0.000163	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-B—multiple sclerosis	4.25e-05	0.000161	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PGR—multiple sclerosis	4.25e-05	0.000161	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCR3—multiple sclerosis	4.16e-05	0.000157	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD28—multiple sclerosis	4.12e-05	0.000156	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TYK2—multiple sclerosis	4.11e-05	0.000155	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—multiple sclerosis	4.05e-05	0.000153	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR2—multiple sclerosis	4.05e-05	0.000153	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.01e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.01e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.98e-05	0.000151	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.98e-05	0.000151	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2RA—multiple sclerosis	3.98e-05	0.00015	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD86—multiple sclerosis	3.94e-05	0.000149	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-A—multiple sclerosis	3.93e-05	0.000149	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.89e-05	0.000147	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL5—multiple sclerosis	3.88e-05	0.000147	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.82e-05	0.000145	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—multiple sclerosis	3.76e-05	0.000142	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CNR1—multiple sclerosis	3.74e-05	0.000141	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SRM—multiple sclerosis	3.73e-05	0.000141	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.71e-05	0.00014	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.67e-05	0.000139	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD80—multiple sclerosis	3.66e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.64e-05	0.000138	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—multiple sclerosis	3.6e-05	0.000136	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—multiple sclerosis	3.59e-05	0.000136	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SPP1—multiple sclerosis	3.59e-05	0.000136	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—multiple sclerosis	3.52e-05	0.000133	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—multiple sclerosis	3.49e-05	0.000132	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.49e-05	0.000132	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—multiple sclerosis	3.48e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.45e-05	0.000131	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—multiple sclerosis	3.45e-05	0.00013	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—multiple sclerosis	3.44e-05	0.00013	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—multiple sclerosis	3.42e-05	0.000129	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—multiple sclerosis	3.4e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.4e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.4e-05	0.000129	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—multiple sclerosis	3.37e-05	0.000127	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MAPK1—multiple sclerosis	3.33e-05	0.000126	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.32e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD80—multiple sclerosis	3.32e-05	0.000126	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—BCHE—multiple sclerosis	3.3e-05	0.000125	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—multiple sclerosis	3.18e-05	0.00012	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.11e-05	0.000118	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TYK2—multiple sclerosis	3.09e-05	0.000117	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MAPK1—multiple sclerosis	3.06e-05	0.000116	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.000115	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—multiple sclerosis	3.02e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD86—multiple sclerosis	2.94e-05	0.000111	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL5—multiple sclerosis	2.9e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.88e-05	0.000109	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD80—multiple sclerosis	2.87e-05	0.000109	CbGpPWpGaD
Irbesartan—JUN—Immune System—TYK2—multiple sclerosis	2.8e-05	0.000106	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—multiple sclerosis	2.76e-05	0.000104	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—multiple sclerosis	2.73e-05	0.000103	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SPP1—multiple sclerosis	2.68e-05	0.000101	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—multiple sclerosis	2.67e-05	0.000101	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—multiple sclerosis	2.62e-05	9.93e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	9.93e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	9.93e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MAPK1—multiple sclerosis	2.61e-05	9.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—multiple sclerosis	2.61e-05	9.87e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.58e-05	9.75e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—multiple sclerosis	2.57e-05	9.73e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2RA—multiple sclerosis	2.57e-05	9.73e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—multiple sclerosis	2.56e-05	9.68e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—multiple sclerosis	2.54e-05	9.59e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.47e-05	9.34e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—multiple sclerosis	2.43e-05	9.21e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TYK2—multiple sclerosis	2.43e-05	9.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.4e-05	9.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—multiple sclerosis	2.37e-05	8.98e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—multiple sclerosis	2.35e-05	8.9e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—multiple sclerosis	2.34e-05	8.85e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.34e-05	8.85e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—multiple sclerosis	2.33e-05	8.82e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.25e-05	8.52e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STAT3—multiple sclerosis	2.16e-05	8.19e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD80—multiple sclerosis	2.15e-05	8.12e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.13e-05	8.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—multiple sclerosis	2.04e-05	7.71e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—multiple sclerosis	2.02e-05	7.63e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—multiple sclerosis	2.01e-05	7.61e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.01e-05	7.6e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—multiple sclerosis	2.01e-05	7.6e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—multiple sclerosis	2.01e-05	7.59e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2e-05	7.56e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—multiple sclerosis	2e-05	7.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.99e-05	7.52e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—multiple sclerosis	1.98e-05	7.5e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK1—multiple sclerosis	1.97e-05	7.44e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—STAT3—multiple sclerosis	1.96e-05	7.42e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—multiple sclerosis	1.91e-05	7.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.83e-05	6.93e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TYK2—multiple sclerosis	1.81e-05	6.85e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK1—multiple sclerosis	1.78e-05	6.75e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.75e-05	6.61e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.73e-05	6.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.72e-05	6.5e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—multiple sclerosis	1.7e-05	6.44e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—multiple sclerosis	1.7e-05	6.42e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—multiple sclerosis	1.58e-05	5.97e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—multiple sclerosis	1.57e-05	5.95e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.57e-05	5.92e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—multiple sclerosis	1.55e-05	5.87e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK1—multiple sclerosis	1.54e-05	5.84e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—multiple sclerosis	1.51e-05	5.72e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—multiple sclerosis	1.51e-05	5.7e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.48e-05	5.6e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—multiple sclerosis	1.43e-05	5.4e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—multiple sclerosis	1.37e-05	5.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—multiple sclerosis	1.28e-05	4.84e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—multiple sclerosis	1.27e-05	4.8e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—multiple sclerosis	1.19e-05	4.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—multiple sclerosis	1.18e-05	4.46e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—multiple sclerosis	1.18e-05	4.45e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK1—multiple sclerosis	1.15e-05	4.36e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.14e-05	4.32e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—multiple sclerosis	1.1e-05	4.16e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—multiple sclerosis	1.05e-05	3.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—multiple sclerosis	1.04e-05	3.94e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—multiple sclerosis	1e-05	3.79e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—multiple sclerosis	9.03e-06	3.42e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—multiple sclerosis	8.95e-06	3.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—multiple sclerosis	8.91e-06	3.37e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—multiple sclerosis	8.86e-06	3.35e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—multiple sclerosis	8.23e-06	3.11e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—multiple sclerosis	8.16e-06	3.09e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—multiple sclerosis	7.65e-06	2.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—multiple sclerosis	6.98e-06	2.64e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—multiple sclerosis	6.87e-06	2.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—multiple sclerosis	5.9e-06	2.23e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—multiple sclerosis	5.38e-06	2.04e-05	CbGpPWpGaD
